awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q55053748-A3746D3A-C01A-48FA-9322-6915DD8EA208
Q55053748-A3746D3A-C01A-48FA-9322-6915DD8EA208
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55053748-A3746D3A-C01A-48FA-9322-6915DD8EA208
Sorafenib in the treatment of thyroid cancer.
P2860
Q55053748-A3746D3A-C01A-48FA-9322-6915DD8EA208
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55053748-A3746D3A-C01A-48FA-9322-6915DD8EA208
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f4201798c0fc613be81822fe54759ae460fdb41
P2860
Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancer.